NYSEMKT: VTAKCatheter Precision Inc Stock Ownership - Who owns Catheter Precision?
Insider buying vs selling
Have Catheter Precision Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David A. Jenkins | Executive Chairman and CEO | 2024-01-23 | 9,528 | $0.60 | $5.70kBuy |
| David A. Jenkins | Executive Chairman and CEO | 2024-01-22 | 9,528 | $0.43 | $4.09kBuy |
| David A. Jenkins | Executive Chairman and CEO | 2024-01-19 | 8,470 | $0.42 | $3.59kBuy |
| David A. Jenkins | Executive Chairman and CEO | 2024-01-18 | 8,470 | $0.41 | $3.49kBuy |
| David A. Jenkins | Executive Chairman and CEO | 2024-01-16 | 8,470 | $0.39 | $3.31kBuy |
| David A. Jenkins | Executive Chairman and CEO | 2024-01-16 | 7,793 | $0.39 | $3.01kBuy |
VTAK insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VTAK insiders and whales buy or sell their stock.
VTAK Shareholders
What type of owners hold Catheter Precision Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Dean Irwin | 36.91% | 2,795,201 | $1.54M | Insider |
| Martin Burstein | 4.62% | 350,000 | $192.50k | Insider |
| David A. Jenkins | 4.39% | 332,120 | $182.67k | Insider |
| Armistice Capital LLC | 3.21% | 243,268 | $133.80k | Institution |
| Baird Financial Group Inc | 1.33% | 100,582 | $55.32k | Institution |
| Maurice Buchbinder | 0.93% | 70,475 | $38.76k | Insider |
| Susanne Meline | 0.57% | 43,411 | $23.88k | Insider |
| Thomas G. Fogarty | 0.43% | 32,894 | $18.09k | Insider |
| Martin J. Colombatto | 0.41% | 30,939 | $17.02k | Insider |
| Geode Capital Management LLC | 0.39% | 29,483 | $16.22k | Institution |
VTAK vs Medical Device Stocks
Catheter Precision Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.